Saul Ewing

Saul Ewing LLP: Patent Litigation Summary

Saul Ewing LLP is a large, full-service national law firm with more than 400 attorneys across 18 offices in the United States. The firm, which resulted from the 2017 merger of Saul Ewing and the Chicago-based Arnstein & Lehr LLP, has a significant East Coast presence, with its headquarters in Philadelphia, and offices extending to California and Florida. While not strictly an IP boutique, the firm maintains a robust intellectual property practice that is nationally recognized, particularly in the life sciences sector.

The firm's patent litigation practice has a pronounced specialty in the pharmaceutical and life sciences industries, with a notable focus on Hatch-Waxman/ANDA litigation. Attorneys in this practice group represent branded pharmaceutical companies in disputes against generic drug manufacturers. Beyond pharmaceuticals, the firm's lawyers have handled patent disputes across a range of technologies, including medical devices, software, mechanical devices, and telecommunications. The provided case list shows the firm exclusively on the defendant side in the two tracked matters, representing operating companies. This defensive posture aligns with their broader practice of representing established companies in various industries.

Key partners in the IP litigation group include William C. Baton, who concentrates on Hatch-Waxman litigation for branded pharmaceutical companies, and Joseph M. Kuo, whose practice covers a wide array of IP matters, including patent litigation in technologies such as computer software, medical devices, and automotive products. The firm notes its experience in trials and appeals before federal courts and the U.S. Court of Appeals for the Federal Circuit. The firm also represents clients in proceedings before the Patent Trial and Appeal Board (PTAB), handling inter partes reviews (IPRs), though public data on their filing volume is not readily available.